NuevaCare recently announced that it will be presenting MnemeTherapy®, its service to address Alzheimer’s disease, at two upcoming seminars. The first will be held on Wednesday, May 6 at the PSA Annual Regional Stroke Conference at The Magnolia of Millbrae; the second will take place on Wednesday, May 13 at the Dementia…
News
A recent meeting convened by the National Institutes of Health (NIH) could dramatically alter how researchers study Alzheimer’s disease (AD).  The NIH issued new recommendations, based on the recent Alzheimer’s Disease Research Summit, which could speed up work leading to the development of treatments for AD. During the summit, more…
CereSpirâ„¢ Incorporated, a biotechnology company firm advancing CSP-1103, which is a first-in-class modulator of the innate immune system of the brain to address treatment for Alzheimer’s disease, recently announced that Sophie Egholm has been appointed as Chief Operating Officer of the company. Egholm is a pharmacologist and medicinal chemist who has spent her…
A team of researchers from the University of California, San Diego School of Medicine and Cenna Biosciences, Inc. were able to identify in mice, compounds that inhibit the production of beta amyloid peptides. The results published in the journal PLOS ONE may offer a potential early intervention for…
Samsung Tomorrow, the Samsung Electronics Official Global Blog, reports that about a year ago Samsung Electronics Tunisia (SETN) marketing manager for mobile products Azer Jaafoura and several colleagues began developing a smartphone app for helping out Alzheimer’s Disease (AD) patients. “We wanted to make life easier for Alzheimer’s patients…
Hartford Foundation Reports Success Of NLN’s Advancing Care Excellence For Seniors Program (ACE.S)
The National League for Nursing’s Advancing Care Excellence for Seniors (ACE.S) is committed to preparing nurses so that they can provide high quality and culturally sensitive care to older adults with dementia such as Alzheimer’s disease. According to a recent report by the John A. Hartford Foundation, one of the…
According to a recent press release, MIT will release the results of a novel report that examined the impact of a decline in investment by the U.S. federal government in basic research. Newspersons can attend the event, which will take place in Washington, D.C. During the event, there will be…
Researchers Review the Amyloid Hypothesis Potential to Yield a Therapy for Alzheimer’s Disease
Researchers at the University of Glasgow recently published in the journal Future Science OA a comprehensive review regarding the inhibition of beta-amyloid production as a therapeutic strategy for patients with Alzheimer’s disease. The study is entitled “The role and therapeutic targeting of α-, β—…
According to a recent study published in the journal Neurology, sleep apnea and heavy snoring may be related to thinking and memory decline at an early age. Results from this research also indicate that the decline may be delayed with the use of a breathing machine. “Abnormal…
Voyko Kavcic, Ph.D., a Research Assistant Professor in the Institute of Gerontology at Wayne State University received a grant from the National Institute on Aging of the National Institutes of Health (NIH) to study earlier diagnosis of Alzheimer’s disease (AD). The grant consists of $420,000 over two years…
Recent Posts
- Oral semaglutide fails to slow Alzheimer’s in pair of clinical trials December 2, 2025
- Canada gives conditional OK to early Alzheimer’s drug Leqembi November 4, 2025
- Kisunla approval offers new option to treat early Alzheimer’s in Europe October 3, 2025
- Guest Voice: A journey through loss, love, and remembrance October 2, 2025
- Leqembi OK’d as under-the-skin autoinjector for early Alzheimer’s September 8, 2025